Green Dot Labs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Green Dot Labs - overview
Established
2013
Location
Boulder, CO, US
Primary Industry
Healthcare
About
Green Dot Labs is a cannabis company specializing in premium concentrates, offering high-quality products designed for both connoisseurs and everyday users. Their innovation emphasizes flavor, purity, and a refined selection process. Founded in 2013 in Boulder, US, Green Dot Labs specializes in cannabis concentrates. The company was co-founded by Alana Malone, who has a history of entrepreneurship.
In September 2017, Green Dot Labs secured USD 3. 3 million in Series A funding, led by Tuatara Capital, marking their first investment round. The funding supports their operations and product development, with total capital raised amounting to USD 3. 3 million.
Green Dot Labs specializes in premium cannabis concentrates, featuring products in three core categories: Flower, Live Resin, and Live Rosin. Their offerings include a variety of formats such as dabs, vapes, and infused rolls, all based on proprietary genetics cultivated through a rigorous process. An innovative genetics navigation system categorizes their cultivars, aiding consumers in selecting products based on refinement, flavor, and effects. Initially established in Colorado, the company has expanded to Arizona, launching exclusive flower drops and a full-format rollout to enhance their market reach.
Green Dot Labs generates revenue through a combination of direct-to-consumer sales and partnerships with retailers and wholesalers. Their products are available in dispensaries across Colorado and Arizona, where consumers can purchase individual items or curated selections. Flagship products like Live Resin and Live Rosin are sold through wholesale agreements with dispensaries, enhancing market presence. The pricing structure reflects the quality of their offerings, ensuring a consistent flow of premium cannabis concentrates in the market.
In 2017, Green Dot Labs raised USD 3. 3 million in Series A funding led by Tuatara Capital. The company is focused on developing new products and plans to expand into additional markets, targeting specific geographic regions for growth. Future initiatives may include launching innovative product lines designed to meet evolving consumer demands.
Current Investors
Tuatara Capital
Primary Industry
Healthcare
Sub Industries
Alternative Medicine, Crop Production
Website
www.greendotlabs.com
Verticals
Cannabis/Medical Marijuana, E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.